[Acute coronary syndrome in the elderly. Optimal revascularisation strategies]

M H Wehr1

  • 1Klinik für Kardiologie und Angiologie, Augusta-Kranken-Anstalt Bochum, Bergstrasse 26, Bochum, Germany. m.wehr@augusta-bochum.de

Der Internist
|July 25, 2008
PubMed

Insights

Elderly patients with acute coronary syndromes often miss life-saving treatments due to fears of adverse effects. Early revascularization significantly benefits older individuals, improving outcomes despite higher complication risks.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Internal Medicine

Context:

  • Acute coronary syndromes (ACS) and ST-segment elevation myocardial infarction (STEMI) have established treatment guidelines.
  • Elderly patients present unique challenges in treatment decision-making due to comorbidities and fear of adverse effects.

Purpose:

  • To critically examine the evidence for medical and revascularization therapies in elderly patients with ACS.
  • To address the underutilization of potentially life-saving treatments in older populations.

Summary:

  • Many elderly patients with ACS do not receive timely percutaneous coronary intervention or thrombolytic therapy.
  • Delayed or withheld revascularization in the elderly can lead to irreversible myocardial damage.
  • Evidence indicates substantial benefits and improved outcomes for older patients receiving early ACS treatments, despite increased complication risks.

Impact:

  • Highlights the need for evidence-based treatment strategies tailored to the elderly population with ACS.
  • Encourages the adoption of timely and appropriate revascularization therapies in older adults.
  • Aims to improve clinical outcomes and reduce mortality in elderly patients experiencing acute coronary events.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...